Minority resistant HIV-1 variants and the response to first-line NNRTI therapy.

@article{Nicot2015MinorityRH,
  title={Minority resistant HIV-1 variants and the response to first-line NNRTI therapy.},
  author={Florence Nicot and Karine Saun{\'e} and St{\'e}phanie Raymond and Nicolas Jeanne and Romain Carcenac and Caroline Lefebvre and Lise Cuzin and Bruno Marchou and Pierre Delobel and Jacques Izopet},
  journal={Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology},
  year={2015},
  volume={62},
  pages={20-4}
}
BACKGROUND The presence of low-frequency HIV-1 variants with mutations making them resistant to non-nucleoside reverse-transcriptase inhibitors (NNRTI) could influence the virological response to first-line NNRTI therapy. OBJECTIVES This study was designed to describe the proportions and quantities of NRTI and NNRTI-resistant variants in patients with… CONTINUE READING